| Followers | 245 |
| Posts | 13889 |
| Boards Moderated | 0 |
| Alias Born | 05/19/2015 |
Tuesday, September 07, 2021 8:19:08 AM
Makes one believe the latest prediction that both can’t happen will be proven wrong also!
Think about it If RGBP gets in buyout talks that alone would most likely drive the price much higher and if a bidding war happens there is no telling how high it could run before a buyout.
Many have made much bank here already. By buying and trading instead of listening or following bad advice. I think there will be many more.
How many CEO’s believe in there own company and technology to own this many shares!
Koo’s owns over 197 million shares of the preferred (RGBPP) I OWN MORE SHARES OF RGBP THAN KOO’s! But no one owns more of the rgbpp preferred shares than Koo’s!
This is a little old and has not been updated to new value today.
Koo’s shares alone are now worth more than $30 million dollars at todays price
https://www.marketscreener.com/business-leaders/David-Raymond-Koos-06H0YV-E/biography/
Koo’s owns OVER 47% of RGBPP PREFERRED SHARES!
So which one will be more valuable with a buyout RGBP OR RGBPP!
RGBP OWNS THE PATENTS:
https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=115994843&type=HTML&symbol=RGBP&companyName=Regen+Biopharma+Inc&formType=8-K&formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&dateFiled=2021-07-13&CK=1589150
Lol! Rgbp = money making machine$$$$$$$ see all at higher silver again soon!
This week was just another great RGBP opportunity!
We know how things really work and RGBP is on the fast track to stardom!
Actions speak louder than words!
RGBP IS GOLDEN! RGBP has many patents!
RGBP got 50,000 ONPH SHARES 4-20-21 RGBP RECEIVED PLUS 15 years worth of ROYALTIES just for 1 patent LICENSE DEAL!
Rgbp has many patents and much going for it.
3.1.1. a non-refundable, upfront payment Fifty Thousand shares of Oncology Pharma, Inc. common stock (50,000 shares of ONPH) as a license initiation fee both of which must be paid no later than April 20, 2021 such payment to be made to Regen Biopharma, Inc., a Nevada corporation and the parent of the Licensor.
https://seekingalpha.com/news/3712432-onph-stock-rises-after-company-revealed-plans-for-next-phase-of-growth?utm_source=advfn.com&utm_medium=referral
KEEP YOUR EYES ON THE PRIZE:
RGBP is now CURRENT:
https://sec.report/Ticker/RGBP
!
U
N
D
E
N
I
A
B
L
E
!
Recent RGBP News
- Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025 • GlobeNewswire Inc. • 09/23/2025 12:00:00 PM
- Regen BioPharma Prepares Response For FDA Regarding Its Orphan Drug Application for HemaXellerate • GlobeNewswire Inc. • 09/16/2025 12:00:00 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
